These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 16190557)

  • 1. [Alterations within white blood cell subsets in children with chronic viral hepatitis C before treatment with pegylated interferon and ribavirin].
    Mozer-Lisewska I; Dworacki G; Kaczmarek E; Słuzewski W; Kowala-Piaskowska A; Figlerowicz M; Kaczmarek M; Zeromski J
    Przegl Epidemiol; 2005; 59(2):483-9. PubMed ID: 16190557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of treatment with pegylated interferon and ribavirin in children with chronic hepatitis C].
    Kowala-Piaskowska A; Figlerowicz M; Mozer-Lisewska I; Słuzewski W
    Przegl Epidemiol; 2005; 59(2):491-8. PubMed ID: 16190558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Early virologic response in retherapy with pegylated interferon alpha-2B plus ribavirin in children with chronic hepatitis C].
    Pawłowska M; Palewicz E; Halota W
    Przegl Epidemiol; 2006; 60(1):71-7. PubMed ID: 16758742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current trends and first clinical studies of therapy for chronic hepatitis C in children using pegylated interferon alpha and ribavirin].
    Słuzewski W; Mozer-Lisewska I; Figlerowicz M; Kowala-Piaskowska A; Słuzewska M
    Przegl Epidemiol; 2005; 59(2):595-9. PubMed ID: 16190571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helper T cell cytokine response to ribavirin priming before combined treatment with interferon alpha and ribavirin for patients with chronic hepatitis C.
    Furusyo N; Kubo N; Toyoda K; Takeoka H; Nabeshima S; Murata M; Nakamuta M; Hayashi J
    Antiviral Res; 2005 Jul; 67(1):46-54. PubMed ID: 15913800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy with interferon-alpha and ribavirin for chronic hepatitis C virus infection upregulates membrane HLA-ABC, CD86, and CD28 on peripheral blood mononuclear cells.
    Cheng PN; Wei YL; Chang TT; Chen JS; Young KC
    J Med Virol; 2008 Jun; 80(6):989-96. PubMed ID: 18428145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early virological response in children with chronic hepatitis C treated with pegylated interferon and ribavirin.
    Kowala-Piaskowska A; Słuzewski W; Figlerowicz M; Mozer-Lisewska I
    Infection; 2007 Jun; 35(3):175-9. PubMed ID: 17565459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Peginterferon alpha and ribavirin therapy for difficult-to-treat chronic hepatitis C patients].
    Pawłowska M; Halota W
    Przegl Epidemiol; 2002; 56 Suppl 4():51-4. PubMed ID: 14750261
    [No Abstract]   [Full Text] [Related]  

  • 9. [Long-term viral response to interferon alpha 2b plus ribavirin in chronic hepatitis C patients during standard therapy].
    Adamek A; Adamek J; Juszczyk J; Bereszyńska I
    Przegl Epidemiol; 2007; 61(4):765-70. PubMed ID: 18572509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of toll-like receptors on blood leucocytes of children with chronic viral hepatitis C].
    Mozer-Lisewska I; Słuzewski W; Dworacki G; Kaczmarek M; Kowala-Piaskowska A; Figlerowicz M; Zeromski J
    Przegl Epidemiol; 2006; 60(4):657-63. PubMed ID: 17682745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulatory activities of IFN-gamma1b in combination with type I IFN: implications for the use of IFN-gamma1b in the treatment of chronic HCV infections.
    Wang T; Blatt LM; Seiwert SD
    J Interferon Cytokine Res; 2006 Jul; 26(7):473-83. PubMed ID: 16800786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early viral kinetics and treatment outcome in combination of high-dose interferon induction vs. pegylated interferon plus ribavirin for naive patients infected with hepatitis C virus of genotype 1b and high viral load.
    Tsubota A; Arase Y; Someya T; Suzuki Y; Suzuki F; Saitoh S; Ikeda K; Akuta N; Hosaka T; Kobayashi M; Kumada H
    J Med Virol; 2005 Jan; 75(1):27-34. PubMed ID: 15543591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early HCV RNA changes in patients with chronic hepatitis C treated with peginterferon alfa 2b and ribavirin.
    Gallegos-Orozco JF; Fuentes AP; Olivera-Martinez MA; Gutiérrez-Reyes G; Cortina D; Oregel JA; Pérez-Pruna C; Sixtos MS; Cruz-Castellanos S; Soto-Ramírez LE; Rodríguez-Díaz R; Fuentes-Romero L; Gutiérrez-Ruiz MC; Kershenobich D
    Rev Invest Clin; 2003; 55(2):138-42. PubMed ID: 12827916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interferon alpha, gamma, omega before and during treatment of chronic hepatitis C with pegylated interferon alpha and ribavirin].
    Bolewska B; Czajka A; Moczko J; Juszczyk J
    Przegl Epidemiol; 2007; 61(4):755-63. PubMed ID: 18572508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained virological response to peginterferon plus ribavirin in chronic hepatitis C genotype 1 patients is associated with a persistent Th1 immune response.
    Trapero-Marugán M; García-Buey L; Muñoz C; Quintana NE; Moreno-Monteagudo JA; Borque MJ; Fernández MJ; Salvanés FR; Medina J; Moreno-Otero R
    Aliment Pharmacol Ther; 2006 Jul; 24(1):117-28. PubMed ID: 16803610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell receptor excision circles (TRECs), CD4+, CD8+, and their CD45RO+, and CD45RA+, subpopulations in hepatitis C virus (HCV)-HIV-co-infected patients during treatment with interferon alpha plus ribavirin: analysis in a population on effective antiretroviral therapy.
    Arizcorreta A; Márquez M; Fernández-Gutiérrez C; Guzmán EP; Brun F; Rodríguez-Iglesias M; Girón-González JA
    Clin Exp Immunol; 2006 Nov; 146(2):270-7. PubMed ID: 17034579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ribavirin in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2a plus ribavirin.
    Bronowicki JP; Ouzan D; Asselah T; Desmorat H; Zarski JP; Foucher J; Bourlière M; Renou C; Tran A; Melin P; Hézode C; Chevalier M; Bouvier-Alias M; Chevaliez S; Montestruc F; Lonjon-Domanec I; Pawlotsky JM
    Gastroenterology; 2006 Oct; 131(4):1040-8. PubMed ID: 17030174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological response in chronic hepatitis C virus infection during interferon alpha therapy.
    Panasiuk A; Prokopowicz D; Zak J
    Hepatogastroenterology; 2004; 51(58):1088-92. PubMed ID: 15239252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to pegylated interferon alpha-2b and ribavirin in children with chronic hepatitis C.
    Baker RD; Dee D; Baker SS
    J Clin Gastroenterol; 2007 Jan; 41(1):111-4. PubMed ID: 17198073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial effects of a 24-week course of pegylated-interferon plus ribavirin in asymptomatic HCV/HIV co-infected patients on long-term treatment with didanosine, stavudine or both.
    Ballesteros AL; Miró O; López S; Fuster D; Videla S; Martínez E; Garrabou G; Salas A; Côté H; Tor J; Rey-Joly C; Planas R; Clotet B; Tural C
    Antivir Ther; 2004 Dec; 9(6):969-77. PubMed ID: 15651755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.